↓ Skip to main content

Cochrane Database of Systematic Reviews

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

Overview of attention for article published in this source, April 2010
Altmetric Badge

Citations

dimensions_citation
278 Dimensions

Readers on

mendeley
563 Mendeley
citeulike
6 CiteULike
connotea
1 Connotea
Title
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Published by
John Wiley & Sons, Ltd, April 2010
DOI 10.1002/14651858.cd002967.pub4
Pubmed ID
Authors

Salpeter, Shelley R, Greyber, Elizabeth, Pasternak, Gary A, Salpeter, Edwin E

Abstract

Metformin is an oral anti-hyperglycemic agent that has been shown to reduce total mortality compared to other anti-hyperglycemic agents, in the treatment of type 2 diabetes mellitus. Metformin, however, is thought to increase the risk of lactic acidosis, and has been considered to be contraindicated in many chronic hypoxemic conditions that may be associated with lactic acidosis, such as cardiovascular, renal, hepatic and pulmonary disease, and advancing age.

Twitter Demographics

The data shown below were collected from the profiles of 35 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 563 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 4 <1%
Spain 2 <1%
United States 2 <1%
Italy 1 <1%
Hong Kong 1 <1%
South Africa 1 <1%
Canada 1 <1%
Mexico 1 <1%
Netherlands 1 <1%
Other 4 <1%
Unknown 545 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 81 14%
Researcher 70 12%
Student > Bachelor 69 12%
Student > Postgraduate 65 12%
Student > Ph. D. Student 49 9%
Other 124 22%
Unknown 105 19%
Readers by discipline Count As %
Medicine and Dentistry 294 52%
Nursing and Health Professions 32 6%
Pharmacology, Toxicology and Pharmaceutical Science 31 6%
Agricultural and Biological Sciences 20 4%
Biochemistry, Genetics and Molecular Biology 18 3%
Other 46 8%
Unknown 122 22%